Barriers to Buruli ulcer treatment completion in the Ashanti and Central Regions, Ghana.

ABSTRACT:

Background

Buruli ulcer is a chronic ulcerating skin condition, with the highest burden found in Central and West Africa where it disproportionately affects the most vulnerable populations. Treatment is demanding, comprising eight-weeks of daily antibiotics, regular wound care and possible surgical intervention. Treatment completion is key to optimising outcomes, however the degree of and barriers to this are not well understood. Recent change from injectable treatment (SR8) to oral treatment (CR8) has made it feasible to further decentralise care, potentially improving treatment access and completion. However, the impact of this and of other demographic and clinical influences on treatment completion must be explored first to ensure appropriate models of care are developed.

Met

SUBMITTER: Collinson S 

PROVIDER: S-EPMC7274448 | biostudies-literature | 2020 May

REPOSITORIES: biostudies-literature